1. Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death
   Melkon Iradyan et al, 2019, Cancers CrossRef
2. First Bispecific Inhibitors of the Epidermal Growth Factor Receptor Kinase and the NF-κB Activity As Novel Anticancer Agents
   Mostafa M. Hamed et al, 2017, Journal of Medicinal Chemistry CrossRef
3. Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report
   Wei Jing et al, 2020, Frontiers in Oncology CrossRef
4. Molecular Approaches to Protein Dimerization: Opportunities for Supramolecular Chemistry
   Dung Thanh Dang, 2022, Frontiers in Chemistry CrossRef
5. Lead compound bearing caffeic scaffold induces EGFR suppression in solid tumor cancer cells
   Chawannuch Mudjupa et al, 2015, Journal of Applied Biomedicine CrossRef
6. FITC-conjugated single chain Nimotuzumab can specifically recognize and enter EGFR-overexpressing cells
   Seyedeh Roghayeh Hamidi et al, 2022, International Journal of Peptide Research and Therapeutics CrossRef
7. The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs
   Amanda C. Sharko et al, 2021, Cells CrossRef